Cloud-clone
SKU(재고 관리 코드):PAA717Hu01
Polyclonal Antibody to Hypoxanthine Phosphoribosyltransferase 1 (HPRT1)
Polyclonal Antibody to Hypoxanthine Phosphoribosyltransferase 1 (HPRT1)
;Immunohistochemistry: 5-20µg/mL
;Immunocytochemistry: 5-20µg/mL
;Optimal working dilutions must be determined by end user.
Product No.
PAA717Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPA717Hu01-Recombinant Hypoxanthine Phosphoribosyltransferase 1 (HPRT1)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
Rattus norvegicus (Rat), Sus scrofa; Porcine (Pig)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against HPRT1. It has been selected for its ability to recognize HPRT1 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-5µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| J Crohns Colitis. | Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C. Pubmed:25518051 |
| J Crohns | Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of tenascin C PubMed: 25518051 |
| Molecular Biology Reports | Increased ENT2 Expression and Its Association With Altered Purine Metabolism in Different Stages of Colorectal Cancer Cell Lines |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA717Hu01 | Recombinant Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA717Hu01 | Polyclonal Antibody to Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | WB; IHC; ICC; IP. |
| FAA717Hu01 | Anti-Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) Polyclonal Antibody | Flow cytometry. |
| MAA717Hu22 | Monoclonal Antibody to Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | WB; IHC; ICC; IP. |
| SEA717Hu | ELISA Kit for Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA717Hu | Magnetic Luminex Assay Kit for Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
